IRIS Accounts Production v25.4.0.155 05771934 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Fair value model iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 05771934 2024-03-31 05771934 2025-03-31 05771934 2024-04-01 2025-03-31 05771934 2023-03-31 05771934 2023-04-01 2024-03-31 05771934 2024-03-31 05771934 ns15:EnglandWales 2024-04-01 2025-03-31 05771934 ns14:PoundSterling 2024-04-01 2025-03-31 05771934 ns10:Director1 2024-04-01 2025-03-31 05771934 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05771934 ns10:SmallEntities 2024-04-01 2025-03-31 05771934 ns10:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 05771934 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 05771934 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 05771934 ns10:FullAccounts 2024-04-01 2025-03-31 05771934 ns10:Director2 2024-04-01 2025-03-31 05771934 ns10:Director3 2024-04-01 2025-03-31 05771934 ns10:Director4 2024-04-01 2025-03-31 05771934 ns10:Director5 2024-04-01 2025-03-31 05771934 ns10:RegisteredOffice 2024-04-01 2025-03-31 05771934 ns5:CurrentFinancialInstruments 2025-03-31 05771934 ns5:CurrentFinancialInstruments 2024-03-31 05771934 ns5:Non-currentFinancialInstruments 2025-03-31 05771934 ns5:Non-currentFinancialInstruments 2024-03-31 05771934 ns5:ShareCapital 2025-03-31 05771934 ns5:ShareCapital 2024-03-31 05771934 ns5:SharePremium 2025-03-31 05771934 ns5:SharePremium 2024-03-31 05771934 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 05771934 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 05771934 ns5:PlantMachinery 2024-04-01 2025-03-31 05771934 ns5:PlantMachinery 2024-03-31 05771934 ns5:PlantMachinery 2025-03-31 05771934 ns5:PlantMachinery 2024-03-31 05771934 ns5:CostValuation 2025-03-31 05771934 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31 05771934 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-03-31

REGISTERED NUMBER: 05771934 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Healthcare House Limited

| Healthcare House Limited (Registered number: 05771934) |

Contents of the Financial Statements

for the Year Ended 31 March 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| Healthcare House Limited |

Company Information

for the Year Ended 31 March 2025

| DIRECTORS: | Timothy James Lockett

| Frances Lockett

| Beverley Jane Lockett

| Callum James Lockett

| Freya Elise Lockett

| REGISTERED OFFICE: | 70-72 Kirkgate Silsden

| Keighley

| West Yorkshire

| BD20 0PA

| REGISTERED NUMBER: | 05771934 (England and Wales)

| ACCOUNTANTS: | Marshall Krysko Limited

| 70-72 Kirkgate

| Silsden

| West Yorkshire

| BD20 0PA

| Healthcare House Limited (Registered number: 05771934) |

Balance Sheet

31 March 2025

| 31.3.25 | 31.3.24 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 104,317 |  | 852 |  |

Investments | 5 | 62,448 |  | 62,448 |  |

Investment property | 6 | 2,900,000 |  | 2,900,000 |  |

3,066,765 |  | 2,963,300 |  |

CURRENT ASSETS

Stocks | - |  | 8,577 |  |

Debtors | 7 | 1,549,505 |  | 769,098 |  |

Cash at bank | 11,383 |  | 24,832 |  |

1,560,888 |  | 802,507 |  |

CREDITORS

Amounts falling due within one year | 8 | 1,696,162 |  | 928,837 |  |

NET CURRENT LIABILITIES | (135,274 | ) | (126,330 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 2,931,491 |  | 2,836,970 |  |

CREDITORS

Amounts falling due after more than one year | 9 | (54,166 | ) | - |  |

PROVISIONS FOR LIABILITIES | (244,857 | ) | (168,464 | ) |

NET ASSETS | 2,632,468 |  | 2,668,506 |  |

CAPITAL AND RESERVES

Called up share capital | 20,000 |  | 20,000 |  |

Share premium | 558,571 |  | 558,571 |  |

Retained earnings | 2,053,897 |  | 2,089,935 |  |

2,632,468 |  | 2,668,506 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

| Healthcare House Limited (Registered number: 05771934) |

Balance Sheet - continued

31 March 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 March 2026 and were signed on its behalf by:

Timothy James Lockett - Director

| Healthcare House Limited (Registered number: 05771934) |

Notes to the Financial Statements

for the Year Ended 31 March 2025

1. | STATUTORY INFORMATION

| Healthcare House Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

| Turnover

| Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the rental of investment property is recognised in the period to which the rental services are provided and in accordance with lease agreements.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery etc | - | 33% on reducing balance and 25% on reducing balance

| Investments in associates

| Investments in associate undertakings are measured at cost less any accumulated impairment losses.

| Investment property

| Investment property is carried at fair value determined annually by external valuers and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in profit or loss.

| Stocks

| Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location.

| Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

| At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

| Financial instruments

| The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Healthcare House Limited (Registered number: 05771934) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Debtors

| Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

| Cash and cash equivalents

| Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

| Creditors

| Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 3 (2024 - 3 ) .

4. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 April 2024 | 1,878 |  |

| Additions | 116,009 |  |

| At 31 March 2025 | 117,887 |  |

| DEPRECIATION

| At 1 April 2024 | 1,026 |  |

| Charge for year | 12,544 |  |

| At 31 March 2025 | 13,570 |  |

| NET BOOK VALUE

| At 31 March 2025 | 104,317 |  |

| At 31 March 2024 | 852 |  |

| Healthcare House Limited (Registered number: 05771934) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

5. | FIXED ASSET INVESTMENTS

| Interest

| in

| associate

£ |

| COST

| At 1 April 2024

| and 31 March 2025 | 62,448 |  |

| NET BOOK VALUE

| At 31 March 2025 | 62,448 |  |

| At 31 March 2024 | 62,448 |  |

6. | INVESTMENT PROPERTY

| Total

£ |

| FAIR VALUE

| At 1 April 2024

| and 31 March 2025 | 2,900,000 |  |

| NET BOOK VALUE

| At 31 March 2025 | 2,900,000 |  |

| At 31 March 2024 | 2,900,000 |  |

| Freehold investment property is included at the revalued amount of £2,900,000 based on a Directors valuation and a letter from Holroyd Miller, Chartered Valuation Surveyors on 22 April 2022, at an open market value subject to existing leases. The historic cost of the property is £1,739,201.

| The company values its land and buildings at an open market value subject to existing leases. These are reviewed on a regular basis for reasonableness.

| In the opinion of the directors, the fair value of the freehold investment property at 31 March 2025 does not materially differ from the valuation.

7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.3.25 |  | 31.3.24

£ | £ |

| Trade debtors | 179,783 |  | - |  |

| Other debtors | 1,369,722 |  | 769,098 |  |

1,549,505 |  | 769,098 |  |

8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.3.25 |  | 31.3.24

£ | £ |

| Hire purchase contracts | 2,845 |  | - |  |

| Trade creditors | 12,533 |  | 4,825 |  |

| Taxation and social security | 22,713 |  | 7,998 |  |

| Other creditors | 1,658,071 |  | 916,014 |  |

1,696,162 |  | 928,837 |  |

| Healthcare House Limited (Registered number: 05771934) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

| 31.3.25 |  | 31.3.24

£ | £ |

| Hire purchase contracts | 54,166 |  | - |  |

10. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| Included within other creditors is an amount of £1,645,633 (2024 - £910,259) owed to Timothy Lockett. The balance is interest free and payable on demand.